Wells Fargo
VRDN icon

Wells Fargo’s Viridian Therapeutics VRDN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.12M Buy
79,781
+3,448
+5% +$48.2K ﹤0.01% 3290
2025
Q1
$1.03M Buy
76,333
+11,886
+18% +$160K ﹤0.01% 3248
2024
Q4
$1.24M Buy
64,447
+15,443
+32% +$296K ﹤0.01% 3129
2024
Q3
$1.11M Buy
49,004
+11,546
+31% +$263K ﹤0.01% 3147
2024
Q2
$487K Buy
37,458
+5,330
+17% +$69.3K ﹤0.01% 3593
2024
Q1
$563K Buy
32,128
+6,235
+24% +$109K ﹤0.01% 3477
2023
Q4
$564K Sell
25,893
-46,536
-64% -$1.01M ﹤0.01% 3437
2023
Q3
$1.11M Buy
72,429
+3,542
+5% +$54.3K ﹤0.01% 3019
2023
Q2
$1.64M Buy
68,887
+22,929
+50% +$545K ﹤0.01% 2907
2023
Q1
$1.17M Buy
+45,958
New +$1.17M ﹤0.01% 3060
2022
Q4
Sell
-808
Closed -$16K 7395
2022
Q3
$16K Buy
808
+194
+32% +$3.84K ﹤0.01% 5182
2022
Q2
$7K Buy
614
+303
+97% +$3.45K ﹤0.01% 5616
2022
Q1
$5K Sell
311
-175
-36% -$2.81K ﹤0.01% 6132
2021
Q4
$9K Buy
486
+74
+18% +$1.37K ﹤0.01% 6052
2021
Q3
$7K Sell
412
-107
-21% -$1.82K ﹤0.01% 5978
2021
Q2
$10K Buy
519
+29
+6% +$559 ﹤0.01% 5818
2021
Q1
$8K Buy
490
+2
+0.4% +$33 ﹤0.01% 6038
2020
Q4
$8K Sell
488
-8,410
-95% -$138K ﹤0.01% 5789
2020
Q3
$7K Buy
8,898
+8,643
+3,389% +$6.8K ﹤0.01% 5646
2020
Q2
$0 Buy
255
+2
+0.8% ﹤0.01% 6451
2020
Q1
$0 Buy
+253
New ﹤0.01% 6418
2019
Q3
Sell
-1,290
Closed -$3K 6223
2019
Q2
$3K Sell
1,290
-37,479
-97% -$87.2K ﹤0.01% 5687
2019
Q1
$109K Buy
38,769
+4,309
+13% +$12.1K ﹤0.01% 5020
2018
Q4
$105K Buy
34,460
+9,436
+38% +$28.8K ﹤0.01% 5025
2018
Q3
$139K Buy
25,024
+1,213
+5% +$6.74K ﹤0.01% 4986
2018
Q2
$153K Buy
23,811
+5,100
+27% +$32.8K ﹤0.01% 4965
2018
Q1
$131K Buy
18,711
+907
+5% +$6.35K ﹤0.01% 4966
2017
Q4
$185K Buy
17,804
+11,943
+204% +$124K ﹤0.01% 4817
2017
Q3
$54K Buy
+5,861
New +$54K ﹤0.01% 5170